# US 6,730,675 B2 · Compounds and methods for the treatment of pain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,675 B2
- Document ID: US6730675B2
- Status: Granted
- Kind: B2
- Application number: 10/168,762
- Filed: 2003-02-12
- Published: 2003-08-14
- Granted: 2004-05-04
- Earliest claimed: 1999-12-23
- Assignees: AstraZeneca AB
- Inventors: Megan Murphy; Rebecca Ann Urbanek; Wenhua Xiao; Gary Banks Steelman; Dean Gordon Brown; Thomas Michael Bare
- Web page: https://patentgrep.com/patent/US6730675B2

## CPC

- C07D 471/04: Ortho-condensed systems
- A61K 31/5025: ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/503: spiro-condensed
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 31/541: Non-condensed thiazines containing further heterocyclic rings
- C07D 487/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Compounds according to structural diagram I are disclosed; wherein R1, A and D are as defined in the specification. Also disclosed are methods for treating pain comprising administration of a pain-ameliorating effective amount of a compound in accord with structural diagram I and pharmaceutical compositions comprising a pain-ameliorating effective amount of a compound in accord with structural diagram I.

## Claims

### Claim 1

A compound according to formula I;
wherein:
R1 is halo;
A is (CH2)n where n is a value selected from 1, 2, 3 and 4;
D is a five-membered heteroaryl moiety or a benzo-fused-derivative thereof, said heteroaryl moiety having one or two heteroatoms selected from oxygen, nitrogen and sulfur and having one or two substituents thereon,
said substituents being selected from C1-4alkyl, phenyl, halo-substituted phenyl, halo, carboxy and C1-4alkoxycarbonyl,
or tautomers or pharmaceutically-acceptable salts thereof.

### Claim 2 (depends on 1)

A compound according to claim 1, wherein:
n is a value selected from 1 and 2, and
said substituents are selected from C1-2alkyl, halo-substituted phenyl, halo, carboxy and C1-2alkoxycarbonyl.

### Claim 3 (depends on 1)

A compound of claim 1, according to formula II,

### Claim 4 (depends on 3)

A compound according to claim 3, wherein:
n is a value selected from 1 and 2, and
said substituents are selected from C1-2alkyl, halo-substituted phenyl, halo, carboxy and C1-2alkoxycarbonyl.

### Claim 5 (depends on 4)

A compound according to claim 4, wherein:
n is 1, and
said substituents are selected from methyl, chloro-substituted phenyl, halo and methoxycarbonyl.

### Claim 6 (depends on 1)

A compound according to claim 1, selected from:
7-chloro-4-hydroxy-2-[2,5-dimethyl(3-furanyl)]methyl-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-[(3-methyl(2-thienyl))methyl]-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-(5-methylfuran-2-ylmethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-[2-methylfuran-3-yl]methyl-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-(4-(3,5-dimethyl)isoxazolino)methyl-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-(5-(2-chlorophenyl)furan-2-ylmethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-(4,5-dimethylfuran-2-ylmethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-(5-methylcarboxyfuran-2-ylmethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-(5-methylthien-2-ylmethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione;
7-chloro-4-hydroxy-2-(2-methylbenz[b]thien-2-ylmethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione, and
7-chloro-4-hydroxy-2-(3-methyl-5-bromothien-2-ylmethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione.

### Claim 7

A method for treating a subject suffering from pain comprising administering a pain-ameliorating effective amount of a compound according to formula I
wherein:
R1 is halo;
A is (CH2)n where n is a value selected from 1, 2, 3 and 4;
D is a five-membered heteroaryl moiety or a benzo-fused-derivative thereof, said heteroaryl moiety having one or two heteroatoms selected from oxygen, nitrogen and sulfur and having one or two substituents thereon,
said substituents being selected from C1-4alkyl, phenyl, halo-substituted phenyl, halo, carboxy and C1-4alkoxycarbonyl,
or tautomers or pharmaceutically-acceptable salts thereof.

### Claim 8 (depends on 7)

A method according to claim 7, wherein in said compound according to formula I:
n is a value selected from 1 and 2, and
said substituents are selected from C1-2alkyl, halo-substituted phenyl, halo, carboxy and C1-2alkoxycarbonyl.

### Claim 9 (depends on 8)

A method according to claim 8, wherein in said compound according to formula I:
n is 1, and
said substituents are selected from methyl, chloro-substituted phenyl, halo and methoxycarbonyl.

### Claim 10

A pharmaceutical composition comprising a pain-ameliorating effective amount of a compound according to formula I together with a pharmaceutically-acceptable excipient or diluent;
wherein:
R1 is halo;
A is (CH2)n where n is a value selected from 1, 2, 3 and 4;
D is a five-membered heteroaryl moiety or a benzo-fused-derivative thereof, said heteroaryl moiety having one or two heteroatoms selected from oxygen, nitrogen and sulfur and having one or two substituents thereon,
said substituents being selected from C1-4alkyl, phenyl, halo-substituted phenyl, halo, carboxy and C1-4alkoxycarbonyl,
or tautomers or pharmaceutically-acceptable salts thereof.
